acetylleucyl-leucyl-norleucinal and Hodgkin Disease

acetylleucyl-leucyl-norleucinal has been researched along with Hodgkin Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allmer, C; Ansell, SM; Asmann, YW; Canioni, D; Casasnovas, O; Cerhan, JR; Cozen, W; Delarue, R; Dogan, A; Dupuis, J; Farrell, K; Ghesquières, H; Habermann, TM; Jarrett, RF; Larrabee, BR; Link, BK; Maurer, MJ; McKay, JD; Montgomery, D; Perrot, A; Salles, G; Slager, SL; Verney, A	1

Other Studies

1 other study(ies) available for acetylleucyl-leucyl-norleucinal and Hodgkin Disease

Article	Year
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts. British journal of haematology, 2018, Volume: 180, Issue:2 Topics: Chromosomes, Human, Pair 8; Genes, myc; Genetic Loci; Genetic Predisposition to Disease; Hodgkin Disease; Humans; Leupeptins; Polymorphism, Single Nucleotide; Prognosis; RNA, Long Noncoding; Survival Analysis	2018

Article

Year

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.

British journal of haematology, 2018, Volume: 180, Issue:2

Topics: Chromosomes, Human, Pair 8; Genes, myc; Genetic Loci; Genetic Predisposition to Disease; Hodgkin Disease; Humans; Leupeptins; Polymorphism, Single Nucleotide; Prognosis; RNA, Long Noncoding; Survival Analysis

2018